ASX 200 8,124.50 ▲ +1.2% AUD/USD 0.6542 ▼ -0.3% BHP $45.20 ▲ +2.1% CBA $112.80 ▲ +0.8% Gold $2,342 ▲ +0.5% Iron Ore $108.50 ▼ -1.1% CSL $298.40 ▲ +1.5% Oil (Brent) $82.30 ▼ -0.4% ASX 200 8,124.50 ▲ +1.2% AUD/USD 0.6542 ▼ -0.3% BHP $45.20 ▲ +2.1% CBA $112.80 ▲ +0.8% Gold $2,342 ▲ +0.5% Iron Ore $108.50 ▼ -1.1% CSL $298.40 ▲ +1.5% Oil (Brent) $82.30 ▼ -0.4%
ATH Health Care Sector News

Alterity Therapeutics Ltd

About ATH

A clinical-stage biotechnology company developing treatments for neurodegenerative conditions including Parkinson's disease, Alzheimer's disease, and Huntington's disease.

All News for ATH

No news articles found for ATH yet.